Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

The Effects of Virtual Reality-Based Relaxation on Postoperative Symptoms and Patient Satisfaction Among Adolescents Undergoing Emergency Surgery

16 de novembro de 2026 atualizado por: Aynur Çakmak, Dokuz Eylul University

Investigation of the Effects of Virtual Reality-Based Relaxation Exercises on Postoperative Symptom Management and Patient Satisfaction in Adolescents Undergoing Emergency Surgical Intervention

The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction among adolescents undergoing emergency surgery. Specifically, the study will investigate the effects of these exercises on preoperative and postoperative anxiety levels, pain intensity scores, nausea and vomiting scores, time to mobilization (hours), total length of hospital stay (hours), and patient satisfaction.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Descrição detalhada

The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction in adolescents undergoing emergency surgical procedures. Specifically, the study will examine the effects of this intervention on preoperative and postoperative anxiety levels, pain intensity, nausea and vomiting severity, time to first mobilization (hours), total length of hospital stay (hours), and patient satisfaction.

Tipo de estudo

Intervencional

Inscrição (Estimado)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

    • Balçova
      • Izmir, Balçova, Turquia (Türkiye)
        • Dokuz Eylül University Research and Application Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

12 anos a 18 anos (Filho, Adulto)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Inclusion Criteria:
  • Adolescents aged 12-18 years who voluntarily agree to participate in the study,
  • Undergoing surgery for the first time,
  • Scheduled to undergo emergency surgery within 24 hours of hospital admission (appendicitis, ovarian torsion, testicular torsion, or Meckel's diverticulum),
  • Having no chronic diseases (e.g., diabetes, hypertension, asthma, cerebral palsy, epilepsy, cystic fibrosis, etc.),
  • Having no visual, hearing, or physical disabilities,
  • Being oriented to person, place, and time,
  • Having no cognitive impairment that would affect their ability to express themselves,
  • Adolescents for whom written informed consent has been obtained from both the adolescent and their parent.

Exclusion Criteria:

  • Adolescents who do not complete all stages of the study,
  • Adolescents who are admitted to the intensive care unit after surgery,
  • Adolescents whose surgery is postponed beyond the first 24 hours,
  • Adolescents who undergo surgery due to perforated appendicitis,
  • Adolescents diagnosed with migraine, vertigo, or similar conditions,
  • Adolescents who experience hemodynamic instability when wearing the VR headset.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Intervention Group: Virtual Reality

Adolescents and their parents will be informed about the study, and written informed consent will be obtained. Baseline data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State Anxiety Inventory (STAI-S). Participants will receive instructions on VR headset use and relaxation exercises. Before surgery, vital signs, pain, and anxiety will be reassessed. Postoperatively, vital signs, pain, anxiety, and nausea (BARF scale) will be evaluated. At the fourth postoperative hour, following adequate recovery from anesthesia, the VR-based relaxation intervention will be administered. All clinical outcomes will be reassessed at the sixth postoperative hour. Before discharge, patient satisfaction (VAS-S), time to first mobilization, and length of hospital stay will be recorded.

The virtual reality (VR) intervention was implemented using an Oculus Quest 2 headset, selected to ensure patient safety and ease of use. The device is rechargeable, operates independently without requiring a computer connection, weighs 503 g, and is secured to the user's head using adjustable, soft straps. Its hand-tracking feature enables participants to interact naturally with virtual environments using their own hands, without the need for handheld controllers.

The VR-based relaxation program lasts 16 minutes and incorporates rhythmic breathing, controlled exhalation, and progressive muscle relaxation exercises. The progressive muscle relaxation component targets several muscle groups, including the arms and hands, neck, chest and abdomen, legs and hips, back and shoulders, eyes and head, and feet and lower legs.

Sem intervenção: Control Group: Standard Care

During the preoperative period, adolescents and their parents will be informed about the surgical process, and appropriate measures will be taken to ensure patient safety. Adolescents and their parents will also be informed about the study, and written informed consent will be obtained from both parties. During the initial face-to-face interview, data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State-Trait Anxiety Inventory - State Version (STAI-S). Demographic and clinical data will be obtained from the adolescents, their parents, and medical records. Before surgery, vital signs, pain intensity, and state anxiety levels will be reassessed. At the fourth postoperative hour, vital signs, pain intensity, state anxiety, and nausea will be assessed using the BARF scale, while routine nursing care will be provided. At the sixth postoperative hour, these clinical outcomes will be reassessed.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Preoperative Anxiety Level
Prazo: 6 months

Anxiety will be assessed using the Spielberger State Anxiety Inventory (STAI-S), a 20-item scale with total scores ranging from 20 to 80, with higher scores indicating higher levels of anxiety. Two assessments will be conducted during the preoperative period: the first immediately upon the patient's arrival at the surgical ward and the second 30 minutes before transfer to the operating room.

6 months
Postoperative Anxiety Level
Prazo: 6 months

Postoperative anxiety will be assessed on postoperative day 0 using the Spielberger State Anxiety Inventory (STAI-S), a 20-item self-report instrument scored on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of postoperative anxiety. Assessments will be conducted at two time points: 4 and 6 hours after surgery (postoperative day 0).

6 months
Postoperative Pain Intensity
Prazo: 6 months

Postoperative pain intensity will be assessed on postoperative day 0 (POD 0) using a 10-cm Visual Analog Scale (VAS), with scores ranging from 0 to 10. A score of 0 indicates no pain, whereas a score of 10 represents the worst imaginable pain. Assessments will be performed at 4 and 6 hours after surgery.

6 months

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Postoperative Nausea Severity
Prazo: 6 months

Postoperative nausea severity will be assessed using the Baxter Retching Faces (BARF) Scale, with scores ranging from 0 to 10. A score of 0 indicates no nausea, whereas a score of 10 represents the most severe nausea. Assessments will be conducted at two time points: 4 and 6 hours after surgery.

6 months
Postoperative Length of Hospital Stay
Prazo: 6 months

Total duration of postoperative hospitalization, measured in hours from the completion of the surgical procedure until the adolescent patient is formally discharged from the hospital.

6 months
Patient satisfaction level
Prazo: 6 months

Visual Analog Scale for Satisfaction (VAS-S): Patient satisfaction with nursing care will be assessed using a 10-cm visual analog scale ranging from 0 (not satisfied at all) to 10 (completely satisfied), with higher scores indicating greater satisfaction. The assessment will be performed at the 6th postoperative hour on the day of surgery (POD 0).

6 months
At the First Postoperative Mobilization Session
Prazo: 6 months

The total duration (in minutes) of active ambulation performed by the adolescent patient during the first postoperative mobilization session on postoperative day 0 (POD 0).

6 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

20 de novembro de 2026

Conclusão Primária (Estimado)

10 de abril de 2027

Conclusão do estudo (Estimado)

10 de agosto de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

4 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • DEU-SBF-AC-01

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .